Yong-Xing Yao

Dr. Yong-Xing Yao


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2018 in Experimental Neurobiology
Verified
Journal Article
Open access
PDF file
JLJia-Piao Lin
Jia-Piao Lin
CCChao-Qin Chen
Chao-Qin Chen
LHLing-Er Huang
Ling-Er Huang
NLNa-Na Li
Na-Na Li
YYYan Yang
Yan Yang
YYYong-Xing Yao
Yong-Xing Yao
Lin JP, et al. Exp Neurobiol. 2018 Aug;27(4):267-276. https://doi.org/10.5607/en.2018.27.4.267

26 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SGShao-Hui Guo
Shao-Hui Guo
JLJia-Piao Lin
Jia-Piao Lin
LHLing-Er Huang
Ling-Er Huang
YYYan Yang
Yan Yang
CCChao-Qin Chen
Chao-Qin Chen
YYYong-Xing Yao
Yong-Xing Yao
Accumulating evidence suggests a potential role of transient receptor potential vanilloid 1 (TRPV1) channels in inflammatory and cancer-related pain. However, the role of TRPV1 in the maintenance of neuropathic pain remains elusive. The current study investigated the effects of transient Trpv1 gene silencing using a small interference RNA (siRNA) on neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve in rats. Seven days after CCI, the TRPV1 siRNA was intrathecally administered (5 µg/15 µl, once daily for 2 days). TRPV1 and Ca2+/calmodulin-dependent protein kinase II (CAMKII) expression and extracellular signal-regulated kinase (ERK) phosphorylation in the spinal cord were detected using western blotting. The thresholds to mechanical and thermal stimuli were determined before and after intrathecal TRPV1 siRNA administration. TRPV1 and CAMKII expression and ERK2 phosphorylation in the spinal cord were upregulated after CCI. Intrathecal administration of the TRPV1 siRNA not only attenuated behavioural hyperalgesia but also reduced the expression of TRPV1 and CAMKII, as well as ERK2 phosphorylation. Based on these results, silencing of the TRPV1 gene in the spinal cord attenuates the maintenance of neuropathic pain by inhibiting CAMKII/ERK2 activation and suggests that TRPV1 represents a potential target in pain therapy.

20 March 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HLHao-Ling Li
Hao-Ling Li
YHYan Huang
Yan Huang
YZYa-Lan Zhou
Ya-Lan Zhou
RTRun-Hua Teng
Run-Hua Teng
SZShu-Zhuan Zhou
Shu-Zhuan Zhou
YYYong-Xing Yao
Yong-Xing Yao
Neuropathic pain is among the most debilitating forms of chronic pain. Studies have suggested that chronic pain pathogenesis involves neuroimmune interactions and blood–spinal cord barrier (BSCB) disruption. However, the underlying mechanisms are poorly understood. We modeled neuropathic pain in rats by inducing chronic constriction injury (CCI) of the sciatic nerve and analyzed the effects on C-X-C motif chemokine 10 (CXCL10)/CXCR3 activation, BSCB permeability, and immune cell migration from the circulation into the spinal cord. We detected CXCR3 expression in spinal neurons and observed that CCI induced CXCL10/CXCR3 activation, BSCB disruption, and mechanical hyperalgesia. CCI-induced BSCB disruption enabled circulating T cells to migrate into the spinal parenchyma. Intrathecal administration of an anti-CXCL10 antibody not only attenuated CCI-induced hyperalgesia, but also reduced BSCB permeability, suggesting that CXCL10 acts as a key regulator of BSCB integrity. Moreover, T cell migration may play a critical role in the neuroimmune interactions involved in the pathogenesis of CCI-induced neuropathic pain. Our results highlight CXCL10 as a new potential drug target for the treatment of nerve injury–induced neuropathic pain.

18 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LHLing-Er Huang
Ling-Er Huang
SGShao-Hui Guo
Shao-Hui Guo
LTLalita Thitiseranee
Lalita Thitiseranee
YYYan Yang
Yan Yang
YZYan-Feng Zhou
Yan-Feng Zhou
YYYong-Xing Yao
Yong-Xing Yao
Postsynaptic density-95 (PSD-95) is a synaptic scaffolding protein that plays a crucial role in the development of neuropathic pain. However, the underlying mechanism remains unclear. To address the role of PSD-95 in N-methyl-D-aspartate receptor subtype 2B (NR2B) -mediated chronic pain, we investigated the relationship between PSD-95 activation and NR2B function in the spinal cord, by using a rat model of sciatic nerve chronic constriction injury (CCI). We demonstrate that the expression levels of total PSD-95 and cAMP response element binding protein (CREB), as well as phosphorylated NR2B, PSD-95, and CREB, in the spinal dorsal horn, and the interaction of NR2B with PSD-95 were increased in the CCI animals. Intrathecal injection of the selective NR2B antagonist Ro 25-6981 increased paw withdrawal latency, in a thermal pain assessment test. Moreover, repeated treatment with Ro 25-6981 markedly attenuated the thermal hypersensitivity, and inhibited the CCI-induced upregulation of PSD-95 in the spinal dorsal horn. Furthermore, intrathecal injection of the PSD-95 inhibitor strikingly reversed the thermal and mechanical hyperalgesia. Our results suggest that blocking of NR2B signaling in the spinal cord could be used as a therapeutic candidate for treating neuropathic pain.

1 October 2020 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Open access
PDF file
SGShao-Hui Guo
Shao-Hui Guo
SZSheng-Mei Zhu
Sheng-Mei Zhu
YYYong-Xing Yao
Yong-Xing Yao
Acute respiratory distress syndrome and profound hypoxemia are the main causes of death in coronavirus disease-2019 pneumonia. Ruan Q. Yang K. Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China. Intensive Care Med. 2020; 46 : 846-848 Crossref PubMed Scopus (851) Google Scholar Despite the wide use of mechanical ventilation with low-volume, low-pressure, and prone position ventilation strategies, the mortality is still as high as 60% in severe cases. Yang X. Yu Y. Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8 : 475-481 Abstract Full Text Full Text PDF PubMed Scopus (1783) Google Scholar In such situations, ECMO might be a life-saving measure, but it also is associated with hemorrhagic complications. Henry B.M. COVID-19, ECMO, and lymphopenia: A word of caution. Lancet Respir Med. 2020; 8 : e24 Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar , Augoustides J.G. Extracorporeal membrane oxygenation – crucial considerations during the coronavirus crisis. J Cardiothorac Vasc Anesth. 2020; 34 : 1720-1722 Abstract Full Text Full Text PDF PubMed Scopus (9) Google Scholar In addition, because of a relatively complex management, various complications may occur during ECMO support. Keller S.P. Contemporary approaches in the use of extracorporeal membrane oxygenation to support patients waiting for lung transplantation. Ann Cardiothorac Surg. 2020; 9 : 29-41 Crossref PubMed Google Scholar , Hoyler M.M. Flynn B. Iannacone E.M. et al. Clinical management of venoarterial extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2020; 34 : 2776-2792 Abstract Full Text Full Text PDF Scopus (4) Google Scholar

25 September 2024 in Cytokine
Verified
Journal Article
Closed access
LDLishuang Duan
Lishuang Duan
YYYong-Xing Yao
Yong-Xing Yao
HKHai-Ying Kong
Hai-Ying Kong
YZYanfeng Zhou
Yanfeng Zhou
DCDawei Cui
Dawei Cui